SPRBListing•businesswire•
Spruce Biosciences Resumes Trading on the Nasdaq Capital Market
Sentiment:Negative (30)
Summary
(NASDAQ:SPRB) SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, announced that it will resume trading on the Nasdaq Capital Market at the market open today, September 15, 2025, under the ticker symbol “SPRB” and CUSIP 85209E 208. About Spruce Biosciences Spruce Biosciences is a late-stage biopharmaceutical company
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 15, 2025 by businesswire